Wu Chenkai, Shlipak Michael G, Stawski Robert S, Peralta Carmen A, Psaty Bruce M, Harris Tamara B, Satterfield Suzanne, Shiroma Eric J, Newman Anne B, Odden Michelle C
School of Biological and Population Health Sciences, Oregon State University, Corvallis, Oregon, USA;
Department of Medicine, University of California, San Francisco, California, USA.
Am J Hypertens. 2017 Feb;30(2):151-158. doi: 10.1093/ajh/hpw106. Epub 2016 Sep 6.
Level of blood pressure (BP) is strongly associated with cardiovascular (CV) events and mortality. However, it is questionable whether mean BP can fully capture BP-related vascular risk. Increasing attention has been given to the value of visit-to-visit BP variability.
We examined the association of visit-to-visit BP variability with mortality, incident myocardial infarction (MI), and incident stroke among 1,877 well-functioning elders in the Health, Aging, and Body Composition Study. We defined visit-to-visit diastolic BP (DBP) and systolic BP (SBP) variability as the root-mean-square error of person-specific linear regression of BP as a function of time. Alternatively, we counted the number of considerable BP increases and decreases (separately; 10mm Hg for DBP and 20mm Hg for SBP) between consecutive visits for each individual.
Over an average follow-up of 8.5 years, 623 deaths (207 from CV disease), 153 MIs, and 156 strokes occurred. The median visit-to-visit DBP and SBP variability was 4.96 mmHg and 8.53 mmHg, respectively. After multivariable adjustment, visit-to-visit DBP variability was related to higher all-cause (hazard ratio (HR) = 1.18 per 1 SD, 95% confidence interval (CI) = 1.01-1.37) and CV mortality (HR = 1.35, 95% CI = 1.05-1.73). Additionally, individuals having more considerable decreases of DBP (≥10mm Hg between 2 consecutive visits) had higher risk of all-cause (HR = 1.13, 95% CI = 0.99-1.28) and CV mortality (HR = 1.30, 95% CI = 1.05-1.61); considerable increases of SBP (≥20mm Hg) were associated with higher risk of all-cause (HR = 1.18, 95% CI = 1.03-1.36) and CV mortality (HR = 1.37, 95% CI = 1.08-1.74).
Visit-to-visit DBP variability and considerable changes in DBP and SBP were risk factors for mortality in the elderly.
血压水平与心血管事件及死亡率密切相关。然而,平均血压是否能完全反映与血压相关的血管风险仍存在疑问。就诊间血压变异性的价值已受到越来越多的关注。
我们在健康、衰老和身体成分研究中,对1877名功能良好的老年人进行了研究,探讨就诊间血压变异性与死亡率、心肌梗死(MI)发生率和中风发生率之间的关联。我们将就诊间舒张压(DBP)和收缩压(SBP)变异性定义为血压随时间变化的个体特异性线性回归的均方根误差。另外,我们计算了每个个体连续就诊之间舒张压和收缩压显著升高和降低的次数(分别计算;舒张压为10mmHg,收缩压为20mmHg)。
在平均8.5年的随访期内,发生了623例死亡(207例死于心血管疾病)、153例心肌梗死和156例中风。就诊间舒张压和收缩压变异性的中位数分别为4.96mmHg和8.53mmHg。经过多变量调整后,就诊间舒张压变异性与全因死亡率升高相关(每1个标准差的风险比(HR)=1.18,95%置信区间(CI)=1.01-1.37)和心血管死亡率升高相关(HR = 1.35,95%CI = 1.05-1.73)。此外,舒张压有更显著下降(连续两次就诊间下降≥10mmHg)的个体全因死亡率(HR = 1.13,95%CI = 0.99-1.28)和心血管死亡率(HR = 1.30,95%CI = 1.05-1.61)风险更高;收缩压显著升高(≥20mmHg)与全因死亡率(HR = 1.18,95%CI = 1.03-1.36)和心血管死亡率(HR = 1.37,95%CI = 1.08-1.74)风险更高相关。
就诊间舒张压变异性以及舒张压和收缩压的显著变化是老年人死亡的危险因素。